Status:
UNKNOWN
The Use of Digital Genetic Counselor (DGC) for BRCA1/2 Mutation Carrier Testing
Lead Sponsor:
Igentify Ltd
Collaborating Sponsors:
Sheba Medical Center
Conditions:
BRCA Mutations
Eligibility:
FEMALE
18+ years
Brief Summary
The DGC provides an end-to-end solution to the Oncogenetics screening process from participant registration to receipt of the genetic test results and their interpretation. These steps are provided us...
Detailed Description
Step 1. Registration: During the initial phone call with potential participants, qualified staff that are part of the study will explain the process and extend an invitation to participated in the stu...
Eligibility Criteria
Inclusion
- Participants willing to undergo BRCA1/2 genotyping
- Participants willing to use the DGC as part of their genetic screen
- Participants willing to fill up follow up questionnaires about their experience and understanding of the genetic counseling, and share their clinical and DGC usage data with the study personnel
- Fluent in Hebrew
- Age 18 or above
Exclusion
- Individuals that underwent bone marrow transplantation.
- Participants refusing to participate in the study.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 30 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04038905
Start Date
April 1 2020
End Date
April 30 2022
Last Update
January 30 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.